|
🐜
|
mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease
14 auth.
J. Grady,
S. Pickett,
Y. Ng,
C. Alston,
E. Blakely,
S. Hardy,
C. Feeney,
A. Bright,
A. Schaefer,
G. Gorman,
...
R. McNally,
Robert W. Taylor,
D. Turnbull,
R. Mcfarland
|
7 |
2018 |
7
🐜
|
|
🦁
|
Phenotypic heterogeneity in m.3243A>G mitochondrial disease: The role of nuclear factors
10 auth.
S. Pickett,
J. Grady,
Y. Ng,
G. Gorman,
A. Schaefer,
I. Wilson,
...
H. Cordell,
D. Turnbull,
Robert W. Taylor,
R. Mcfarland
|
6 |
2018 |
6
🦁
|
|
🐢
|
The molecular pathology of pathogenic mitochondrial tRNA variants
Uwe Richter,
R. Mcfarland,
Robert W. Taylor,
S. Pickett
|
5 |
2021 |
5
🐢
|
|
🐢
|
Resolving complexity in mitochondrial disease: Towards precision medicine.
R. Boggan,
A. Lim,
Robert W. Taylor,
R. Mcfarland,
S. Pickett
|
4 |
2019 |
4
🐢
|
|
🦁
|
Mitochondrial Donation - Which Women Could Benefit?
8 auth.
S. Pickett,
A. Blain,
Y. Ng,
I. Wilson,
Robert W. Taylor,
R. Mcfarland,
...
D. Turnbull,
G. Gorman
|
4 |
2019 |
4
🦁
|
|
🐜
|
Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease
13 auth.
Chun Chen,
David McDonald,
A. Blain,
A. Sachdeva,
Laura Bone,
Anna L. M. Smith,
C. Warren,
S. Pickett,
G. Hudson,
A. Filby,
...
A. Vincent,
D. Turnbull,
A. Reeve
|
4 |
2021 |
4
🐜
|
|
🐜
|
Height as a Clinical Biomarker of Disease Burden in Adult Mitochondrial Disease
11 auth.
R. Boal,
Y. Ng,
S. Pickett,
A. Schaefer,
C. Feeney,
A. Bright,
...
Robert W. Taylor,
D. Turnbull,
G. Gorman,
T. Cheetham,
R. Mcfarland
|
4 |
2018 |
4
🐜
|
|
🐬
|
Mitochondrial DNA disorders: from pathogenic variants to preventing transmission
Tiago M Bernardino Gomes,
Y. Ng,
S. Pickett,
D. Turnbull,
A. Vincent
|
4 |
2021 |
4
🐬
|
